跳至主要内容
临床试验/DRKS00015860
DRKS00015860招募中不适用

Intensive Care Treatment of Cardiogenic Shock and Post-cardiac Arrest Patients Registry - LMUshock

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 1,000 人开始时间: 2019年11月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with cardiogenic shock or after cardiopulmonary resuscitation of any cause with a minimum age of 18 years, who have been treated on the intensive care unit since the year 2012. Cardiogenic shock was defined by ESC guidelines, the IABP-SHOCK II trial and CULPRIT Shock trial as follows: hypotension despite adequate filling status (systolic blood pressure < 90 mmHg for 30 minutes or catecholamines to maintain systolic blood pressure > 90 mmHg) and signs of pulmonary congestion and at least one of the following clinical and laboratory signs of hypoperfusion: altered mental status, dizziness, cold, clammy skin and extremities, oliguria with urine output < 30ml/h, narrow pulse pressure, metabolic acidosis, elevated serum lactate > 2mmol/l, elevated creatinine, due to primary cardiac dysfunction.

排除标准

  • 未提供

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验

Intensive Care Treatment of Cardiogenic Shock and... | 临床试验